Leerink Partnrs Has Bearish Forecast for Danaher Q1 Earnings

Danaher Co. (NYSE:DHR) – Leerink Partnrs decreased their Q1 2025 earnings per share estimates for Danaher in a report released on Wednesday, January 29th. Leerink Partnrs analyst P. Souda now expects that the conglomerate will post earnings of $1.63 per share for the quarter, down from their previous estimate of $2.02. The consensus estimate for Danaher’s current full-year earnings is $7.77 per share. Leerink Partnrs also issued estimates for Danaher’s Q4 2025 earnings at $2.43 EPS, FY2025 earnings at $7.65 EPS, Q1 2026 earnings at $1.93 EPS, Q2 2026 earnings at $1.96 EPS, Q3 2026 earnings at $2.05 EPS, Q4 2026 earnings at $2.66 EPS and FY2026 earnings at $8.60 EPS.

Other equities analysts have also issued research reports about the company. Citigroup lowered their price objective on Danaher from $285.00 to $265.00 and set a “buy” rating on the stock in a research note on Thursday, January 30th. Guggenheim initiated coverage on Danaher in a research note on Thursday, December 19th. They set a “buy” rating and a $275.00 price objective on the stock. UBS Group lowered their price objective on Danaher from $309.00 to $305.00 and set a “buy” rating on the stock in a research note on Wednesday, October 23rd. Wolfe Research raised Danaher from a “peer perform” rating to an “outperform” rating and set a $285.00 price objective on the stock in a research note on Thursday, October 31st. Finally, Wells Fargo & Company lowered their price objective on Danaher from $280.00 to $240.00 and set an “equal weight” rating on the stock in a research note on Thursday, January 30th. Seven investment analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $278.00.

Danaher Stock Up 0.4 %

Shares of DHR opened at $215.05 on Monday. The stock has a 50 day moving average price of $234.93 and a 200 day moving average price of $252.88. The stock has a market capitalization of $155.33 billion, a price-to-earnings ratio of 40.73, a PEG ratio of 2.80 and a beta of 0.83. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.05 and a current ratio of 1.40. Danaher has a one year low of $210.04 and a one year high of $281.70.

Danaher (NYSE:DHR) last issued its quarterly earnings results on Wednesday, January 29th. The conglomerate reported $2.14 EPS for the quarter, hitting the consensus estimate of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same quarter in the previous year, the business earned $2.09 earnings per share.

Danaher Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, January 31st. Investors of record on Friday, December 27th were paid a dividend of $0.27 per share. This represents a $1.08 annualized dividend and a yield of 0.50%. The ex-dividend date of this dividend was Friday, December 27th. Danaher’s payout ratio is 20.45%.

Insider Buying and Selling

In other Danaher news, SVP Brian W. Ellis sold 5,700 shares of the stock in a transaction dated Thursday, January 30th. The stock was sold at an average price of $224.13, for a total value of $1,277,541.00. Following the sale, the senior vice president now owns 20,230 shares of the company’s stock, valued at $4,534,149.90. This trade represents a 21.98 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 10.90% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Danaher

A number of hedge funds have recently bought and sold shares of DHR. AMF Tjanstepension AB acquired a new stake in Danaher in the 3rd quarter valued at about $5,923,000. Czech National Bank raised its position in Danaher by 4.2% in the 3rd quarter. Czech National Bank now owns 130,939 shares of the conglomerate’s stock valued at $36,404,000 after purchasing an additional 5,320 shares in the last quarter. GAMMA Investing LLC raised its position in Danaher by 33.5% in the 3rd quarter. GAMMA Investing LLC now owns 4,480 shares of the conglomerate’s stock valued at $1,246,000 after purchasing an additional 1,125 shares in the last quarter. WealthBridge Capital Management LLC raised its position in shares of Danaher by 51.8% during the 3rd quarter. WealthBridge Capital Management LLC now owns 1,465 shares of the conglomerate’s stock worth $407,000 after acquiring an additional 500 shares in the last quarter. Finally, Diversified Trust Co raised its position in shares of Danaher by 29.6% during the 3rd quarter. Diversified Trust Co now owns 5,649 shares of the conglomerate’s stock worth $1,571,000 after acquiring an additional 1,289 shares in the last quarter. Institutional investors and hedge funds own 79.05% of the company’s stock.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.